Amazon is considering entering the prescription drug sales market in Japan, the Nikkei newspaper reported on Monday.
Amazon plans to partner with small- and mid-sized pharmacies for the service, starting next year when electronic prescriptions are allowed for the first time in Japan, Nikkei said, citing people involved in the project.
Under this plan, Japanese customers will be able to order prescriptions online after online doctor visits for the first time next year. Major pharmacies and other Japanese companies are also working on similar programs that would give patients digital access to information on their medications.
Read More: Antitrust Chronicle™ – Healthcare
Prescription drug prices in Japan are set by the government, while the distribution system is highly fragmented, with 70 wholesalers nationwide and almost 60,000 pharmacies.
Amazon first moved into the pharmacy business in 2018 with its acquisition of PillPack, a medicine delivery service. It launched its own pharmacy, Amazon Pharmacy, in 2020, reaping important profits from the increased demand during the COVID-19 pandemic.
Amazon’s move into healthcare has not gone unchallenged. Amazon announced plans in late July to buy One Medical, a concierge-type medical service with roughly 190 medical offices in 25 markets. Last week, the e-commerce giant said it would shutter its own hybrid virtual in-home care service called Amazon Care, a One Medical competitor, because it wasn’t meeting customers’ needs.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Japan’s Nippon Steel Eyes Year-End Close on $15B US Steel Deal Amid Political Uncertainty
Nov 7, 2024 by
CPI
Canada Orders Dissolution of TikTok’s Business Amid National Security Concerns
Nov 7, 2024 by
CPI
India Raids Amazon, Flipkart Seller Offices in Foreign Investment Probe
Nov 7, 2024 by
CPI
Canada’s Competition Bureau Seeks Public Feedback on Updated Merger Guidelines
Nov 7, 2024 by
CPI
FTC Adopts Stricter Reporting Rules for Mergers, Delays Expected in 2025
Nov 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Remedies Revisited
Oct 30, 2024 by
CPI
Fixing the Fix: Updating Policy on Merger Remedies
Oct 30, 2024 by
CPI
Methodology Matters: The 2017 FTC Remedies Study
Oct 30, 2024 by
CPI
U.S. v. AT&T: Five Lessons for Vertical Merger Enforcement
Oct 30, 2024 by
CPI
The Search for Antitrust Remedies in Tech Leads Beyond Antitrust
Oct 30, 2024 by
CPI